These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 39096294)
1. Identification and Characterization of a Blood-Brain Barrier Penetrant Inositol Hexakisphosphate Kinase (IP6K) Inhibitor. Heitmann T; Liao G; Ernst G; Poslusney M; van Kralingen T; Li Y; Masi M; DePasquale M; Buchler I; Wei H; Carr GV; Shlevkov E; Lu M; Jessen H; Barrow JC J Med Chem; 2024 Aug; 67(16):13639-13665. PubMed ID: 39096294 [TBL] [Abstract][Full Text] [Related]
2. Fragment-Based Screening Identifies New Quinazolinone-Based Inositol Hexakisphosphate Kinase (IP6K) Inhibitors. Heitmann T; Liao G; de León P; Ernst G; Buchler I; Wei H; Shlevkov E; Brown D; Fitzek M; Collier M; Smith DM; Barrow JC ACS Med Chem Lett; 2023 Dec; 14(12):1760-1766. PubMed ID: 38116421 [TBL] [Abstract][Full Text] [Related]
3. Insights into the roles of inositol hexakisphosphate kinase 1 (IP6K1) in mammalian cellular processes. Chakkour M; Greenberg ML J Biol Chem; 2024 Apr; 300(4):107116. PubMed ID: 38403246 [TBL] [Abstract][Full Text] [Related]
4. Targeting the Inositol Pyrophosphate Biosynthetic Enzymes in Metabolic Diseases. Mukherjee S; Haubner J; Chakraborty A Molecules; 2020 Mar; 25(6):. PubMed ID: 32204420 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a selective inhibitor of inositol hexakisphosphate kinases: use in defining biological roles and metabolic relationships of inositol pyrophosphates. Padmanabhan U; Dollins DE; Fridy PC; York JD; Downes CP J Biol Chem; 2009 Apr; 284(16):10571-82. PubMed ID: 19208622 [TBL] [Abstract][Full Text] [Related]
6. Neuronal migration is mediated by inositol hexakisphosphate kinase 1 via α-actinin and focal adhesion kinase. Fu C; Xu J; Cheng W; Rojas T; Chin AC; Snowman AM; Harraz MM; Snyder SH Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2036-2041. PubMed ID: 28154132 [TBL] [Abstract][Full Text] [Related]
7. Protein kinase- and lipase inhibitors of inositide metabolism deplete IP Rajasekaran SS; Illies C; Shears SB; Wang H; Ayala TS; Martins JO; Daré E; Berggren PO; Barker CJ Cell Signal; 2018 Jan; 42():127-133. PubMed ID: 29042286 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of novel isoform-selective IP6K1 inhibitors. Wormald MM; Ernst G; Wei H; Barrow JC Bioorg Med Chem Lett; 2019 Oct; 29(19):126628. PubMed ID: 31445853 [TBL] [Abstract][Full Text] [Related]
9. The Key Role of IP Minini M; Senni A; Unfer V; Bizzarri M Molecules; 2020 Sep; 25(19):. PubMed ID: 32992691 [TBL] [Abstract][Full Text] [Related]
10. Use of Protein Kinase-Focused Compound Libraries for the Discovery of New Inositol Phosphate Kinase Inhibitors. Puhl-Rubio AC; Stashko MA; Wang H; Hardy PB; Tyagi V; Li B; Wang X; Kireev D; Jessen HJ; Frye SV; Shears SB; Pearce KH SLAS Discov; 2018 Oct; 23(9):982-988. PubMed ID: 29842835 [TBL] [Abstract][Full Text] [Related]
11. Deletion of inositol hexakisphosphate kinase 1 (IP6K1) reduces cell migration and invasion, conferring protection from aerodigestive tract carcinoma in mice. Jadav RS; Kumar D; Buwa N; Ganguli S; Thampatty SR; Balasubramanian N; Bhandari R Cell Signal; 2016 Aug; 28(8):1124-36. PubMed ID: 27140681 [TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction. Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908 [TBL] [Abstract][Full Text] [Related]
13. Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput Screening. Liao G; Ye W; Heitmann T; Ernst G; DePasquale M; Xu L; Wormald M; Hu X; Ferrer M; Harmel RK; Fiedler D; Barrow J; Wei H ACS Pharmacol Transl Sci; 2021 Apr; 4(2):780-789. PubMed ID: 33860201 [TBL] [Abstract][Full Text] [Related]
14. TNP and its analogs: Modulation of IP6K and CYP3A4 inhibition. Lee S; Park BB; Kwon H; Kim V; Jeon JS; Lee R; Subedi M; Lim T; Ha H; An D; Kim J; Kim D; Kim SK; Kim S; Byun Y J Enzyme Inhib Med Chem; 2022 Dec; 37(1):269-279. PubMed ID: 34894957 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors. Ahn M; Park SE; Choi J; Choi J; Choi D; An D; Jeon H; Oh S; Lee K; Kim J; Jang J; Kim S; Byun Y J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2193866. PubMed ID: 37013838 [TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of two human VIP1-like inositol hexakisphosphate and diphosphoinositol pentakisphosphate kinases. Fridy PC; Otto JC; Dollins DE; York JD J Biol Chem; 2007 Oct; 282(42):30754-62. PubMed ID: 17690096 [TBL] [Abstract][Full Text] [Related]
17. Inositol Pyrophosphates: Signaling Molecules with Pleiotropic Actions in Mammals. Lee S; Kim MG; Ahn H; Kim S Molecules; 2020 May; 25(9):. PubMed ID: 32397291 [TBL] [Abstract][Full Text] [Related]